Name: VTVT Income Statement - Vtv Therapeutics Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

VTVT - Vtv Therapeutics Inc.

USD | NASDAQ | Healthcare

VTVT Income Statement - Vtv Therapeutics Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013
Revenues
Revenues	36.8	0.0	1.0	0.0	2.0	4.0	6.4	2.8	12.4	0.3	0.6	0.5	1.5	1.0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	24.0	17.9	11.5	13.6	12.4	13.3	11.0	15.1	23.0	39.6	45.0	27.2	17.4	22.3
Operating Income
Operating Income	(3.0)	(32.8)	(24.2)	(25.5)	(22.5)	(21.7)	(11.9)	(20.9)	(19.8)	(50.7)	(55.0)	(38.1)	(28.9)	(35.8)
Non-Operating
Interest Income	2.4	1.9	1.6	0.5	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	-
Interest Expense
Tax & Net
Income Tax Expense	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.8	0.0	0.0	0.0	-
Net Income From Continuing Ops
Per Share
EPS Basic	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	-
Supplementary Data
EBITDA	-	(32.8)	(24.1)	(25.4)	(22.4)	(21.6)	(11.8)	(20.9)	(19.6)	(50.5)	(54.8)	(37.6)	(28.0)	(34.7)
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	9.0	3.9	7.0	4.1	2.8	2.2	3.2	3.4	2.6	2.1	2.8	4.7	3.9	4.0	3.1	2.2	3.1	5.4	2.4	2.4	3.1	2.5	1.8	2.5	4.2	4.4	3.7	4.2	2.8	2.8	2.7	8.6	8.9	10.1	9.0	9.6	11.0	11.1	10.6	12.1
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	4.6	4.0	3.7	3.6	3.7	2.7	3.3	3.7	4.0	2.6	2.5	3.3	3.5	2.4	2.6	1.8	5.3
Depreciation & Amortization	0.0	-	-	-	0.0	-	-	-	0.0	-	-	-	0.0	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	13.6	7.9	10.7	7.7	6.5	4.9	6.5	7.2	6.6	4.7	5.4	8.0	7.4	6.4	5.7	4.0

Operating Income
Operating Income	23.3	(7.9)	(10.7)	(7.7)	(6.5)	(4.9)	(6.5)	(7.2)	(5.6)	(4.7)	(5.4)	(8.0)	(7.4)	(6.3)	(5.7)	(4.0)	(6.5)	(11.1)	(1.6)	(4.7)	(4.3)	1.8	(2.8)	(4.2)	(6.6)	(6.4)	(5.4)	(4.8)	(4.3)	(0.4)	(1.5)	(8.9)	(9.1)	(12.8)	(11.5)	(12.6)	(13.8)	(13.3)	(13.5)	(14.6)

Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	-	-	0.1	0.0	-	-	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	24.1	(7.1)	(10.3)	(7.4)	(6.2)	(4.4)	(5.8)	(6.4)	(6.0)	(4.4)	(8.5)	(7.2)	(5.8)	(6.1)	(5.5)	(4.1)	(9.4)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	24.1	(7.1)	(10.3)	(7.4)	(6.2)	(4.4)	(5.8)	(6.4)	(6.0)	(4.4)	(8.5)	(7.2)	(5.8)	(6.1)	(5.5)	(4.1)	(9.4)
Net Income Attributable To Parent	24.1	(7.1)	(8.7)	(6.0)	(5.1)	(3.6)	(4.8)	(5.2)	(4.9)	(3.5)	(6.7)	(5.6)	(4.5)	(4.7)	(4.3)	(3.2)
Less: Minority Interest	0.0	0.0	(1.6)	(1.3)	(1.1)	(0.8)	(1.1)	(1.2)	(1.2)	(1.0)	(1.9)	(1.6)	(1.3)	(1.3)	(1.2)	(0.9)	(2.4)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	24.1	(7.1)	(8.7)	(6.0)	(5.1)	(3.6)	(4.8)	(5.2)	(4.9)	(3.5)	(6.7)	(5.6)	(4.5)	(4.7)	(4.3)

Supplementary Data
EBITDA	23.3	-	-	-	(6.5)	-	-	-	(5.6)	-	-	-	(7.4)	-	-	-	(6.5)	-	-	-	(4.3)	-	-	-	(6.6)	-	-	-	(4.3)	-	-	-	(9.1)	-	-	-	(13.7)	-	-	-
EBIT	23.3	(7.9)	(10.7)	(7.7)	(6.5)	(4.9)	(6.5)	(7.2)	(5.6)	(4.7)	(5.4)	(8.0)	(7.4)	(6.3)	(5.7)	(4.0)	(6.5)	(11.1)	(1.6)